EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

Phase 2

Recruiting

Conditions: Recurrent Hepatocellular Carcinoma
Stage III Hepatocellular Carcinoma AJCC V8
Stage IIIA Hepatocellular Carcinoma AJCC V8
Stage IIIB Hepatocellular Carcinoma AJCC V8
Stage IV Hepatocellular Carcinoma AJCC V8
Stage IVA Hepatocellular Carcinoma AJCC V8
Stage IVB Hepatocellular Carcinoma AJCC V8
Unresectable Hepatocellular Carcinoma

Interventions: Other: Laboratory Biomarker Analysis
Drug: Lenvatinib

First Posted Date: 2021-11-02

Last Posted Date: 2024-12-27

Lead Sponsor: Emory University

Target Recruit Count: 19

Registration Number: NCT05103904

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Mayo Clinic Arizona, Scottsdale, Arizona, United States
🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine

Phase 3

Active, not recruiting

Conditions: Meningitis

Interventions: Biological: NmCV-5
Biological: MenACWY-TT

First Posted Date: 2021-10-26

Last Posted Date: 2024-05-07

Lead Sponsor: Emory University

Target Recruit Count: 1325

Registration Number: NCT05093829

Locations: 🇲🇱
Centre pour le Developpement des Vaccins du Mali, Bamako, Mali

Natural Progesterone for the Treatment of Recurrent Glioblastoma

Early Phase 1

Recruiting

Conditions: Gliosarcoma
Recurrent Glioblastoma

Interventions: Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Biological: Therapeutic Progesterone

First Posted Date: 2021-10-25

Last Posted Date: 2024-06-11

Lead Sponsor: Emory University

Target Recruit Count: 32

Registration Number: NCT05091866

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

The Mixed Meal Challenge Study

Not Applicable

Completed

Conditions: Cardiovascular Diseases
Hyperlipidemias

Interventions: Dietary Supplement: Lipid Challenge
Dietary Supplement: Glucose Challenge
Dietary Supplement: Mixed Meal Challenge

First Posted Date: 2021-10-21

Last Posted Date: 2023-05-01

Lead Sponsor: Emory University

Target Recruit Count: 11

Registration Number: NCT05087823

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer

Not Applicable

Active, not recruiting

Conditions: Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage IIB Breast Cancer AJCC v8
Prognostic Stage IB Breast Cancer AJCC v8
Prognostic Stage IIIA Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Prognostic Stage I Breast Cancer AJCC v8
Prognostic Stage IIA Breast Cancer AJCC v8
Anatomic Stage IIIC Breast Cancer AJCC v8
Localized Breast Carcinoma

Interventions: Other: Informational Intervention
Other: Best Practice
Other: Quality-of-Life Assessment
Other: Medical Device Usage and Evaluation
Other: Survey Administration

First Posted Date: 2021-10-21

Last Posted Date: 2024-03-21

Lead Sponsor: Emory University

Target Recruit Count: 33

Registration Number: NCT05086731

Locations: 🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States

and more 1 locations

Mobile HIV Prevention App for Black Women

Not Applicable

Active, not recruiting

Conditions: Mobile Phone Use
Hiv
Stigma, Social

Interventions: Behavioral: in-the-kNOW mobile app
Behavioral: Control

First Posted Date: 2021-10-18

Last Posted Date: 2024-07-03

Lead Sponsor: Emory University

Target Recruit Count: 56

Registration Number: NCT05080972

Locations: 🇺🇸
Center for Black Women's Wellness, Atlanta, Georgia, United States

Parrying the Pitfalls of PrEP: Project PEACH

Phase 4

Active, not recruiting

Conditions: HIV
STI

Interventions: Behavioral: PrEP discontinuation intervention
Drug: Offering of on-demand oral PrEP
Drug: Offering of STI PEP
Drug: Injectable PrEP

First Posted Date: 2021-10-08

Last Posted Date: 2024-06-13

Lead Sponsor: Emory University

Target Recruit Count: 240

Registration Number: NCT05072093

Locations: 🇺🇸
PRISM Research Center, Atlanta, Georgia, United States

Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study

Not Applicable

Recruiting

Conditions: Human Papilloma Virus
Human Papilloma Virus Vaccine

Interventions: Behavioral: CDC 4 Pillars Program

First Posted Date: 2021-10-04

Last Posted Date: 2024-04-18

Lead Sponsor: Emory University

Target Recruit Count: 365

Registration Number: NCT05065840

Locations: 🇺🇸
AHF Lithonia, Lithonia, Georgia, United States
🇺🇸
AID Atlanta, Atlanta, Georgia, United States
🇺🇸
Albany Rural Model Clinic, Albany, Georgia, United States

and more 1 locations

Sleep/Wake State Assessment With Non-invasive Earbuds

Not Applicable

Recruiting

Conditions: Hypersomnolence

Interventions: Device: NextSense EEG-enabled earbuds
Device: Ellcie Healthy eyeglasses
Other: Drug Holiday

First Posted Date: 2021-10-04

Last Posted Date: 2024-02-09

Lead Sponsor: Emory University

Target Recruit Count: 8

Registration Number: NCT05066009

Locations: 🇺🇸
Emory Sleep Center, Atlanta, Georgia, United States

Postpartum Family Planning Program in Rwanda

Not Applicable

Recruiting

Conditions: Family Planning

Interventions: Behavioral: C4 Intervention

First Posted Date: 2021-09-24

Last Posted Date: 2024-02-20

Lead Sponsor: Emory University

Target Recruit Count: 26215

Registration Number: NCT05056545

Locations: 🇷🇼
Project San Francisco, Kigali, Kigali, Kigali Province, Rwanda

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy